On the other hand, miR-133b also directly targets enzymes involved in fatty acid biosynthesis, such as Acaca or Acsl4, whose inhibition may play a role in the decreased hepatic steatosis in EV mice [66,67]. The gene discussed is ACSL4; the disease is fatty liver disease.